Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453059 · ClinicalTrials.gov registry record
Study With Oral Isovue in Abdominopelvic CT
A clinical trial, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- 218
- Enrollment target
NCT04453059 is a clinical trial that has completed, run by Bracco Diagnostics. The registered enrollment target is 218 participants.
The verdict
NCT04453059 has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- 218 participants
- Enrollment target
Study Summary
This is a retrospective clinical study with prospectively designed blinded evaluation of CT images in adult and pediatric patients who underwent CT examinations of the abdomen and pelvis and were orally administered a solution of Isovue-300 to opacify the GI tract to distinguish it from adjacent abdominal and pelvic structures. The study will collect already existing data, such as demographic data, adverse events and CT images, for all chronologically enrolled patients who meet the inclusion/exclusion criteria prospectively defined in this protocol
Interventions
- DRUG Iopamidol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04453059
The ClinicalTrials.gov registry entry for NCT04453059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Iopamidol is the first listed.
NCT04453059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04453059 about?
NCT04453059 is a clinical study titled "Study With Oral Isovue in Abdominopelvic CT". This is a retrospective clinical study with prospectively designed blinded evaluation of CT images in adult and pediatric patients who underwent CT examinations of the abdomen and pelvis and were orally administered a solution of Isovue-300 to opacify the GI tract to distinguish it from adjacent abd...
What is the current status of trial NCT04453059?
This trial is currently completed. The enrollment target is 218 participants. The study started on 2021-07-01. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04453059?
The interventions under investigation include: Iopamidol (DRUG).
Who is sponsoring clinical trial NCT04453059?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.